Prodrug-type anticancer agent using cancer-specific enzymatic activity

[Problem] To provide a novel compound having great potential as a prodrug-type anticancer agent. [Solution] A compound represented by general formula (I) or a salt thereof.

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 21. März Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

URANO YASUTERU [VerfasserIn]
KAMIYA MAKO [VerfasserIn]
HAYASHI KENTO [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07C: Acyclic or carbocyclic compounds (macromolecular co (...)
C07F: Acyclic, carbocyclic, or heterocyclic compounds con (...)
C07H: Sugars; derivatives thereof; nucleosides; nucleotid (...)
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-03-21, Last update posted on www.tib.eu: 2024-04-03, Last updated: 2024-04-09

Patentnummer:

AU2019231422

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000449792